TOX is a critical regulator of tumour-specific T cell differentiation AC Scott, F Dündar, P Zumbo, SS Chandran, CA Klebanoff, M Shakiba, ... Nature 571 (7764), 270-274, 2019 | 843 | 2019 |
A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis MS Glickman, JS Cox, WR Jacobs Molecular cell 5 (4), 717-727, 2000 | 829 | 2000 |
The mechanism of action of BCG therapy for bladder cancer—a current perspective G Redelman-Sidi, MS Glickman, BH Bochner Nature reviews urology 11 (3), 153-162, 2014 | 729 | 2014 |
Determinants of COVID-19 disease severity in patients with cancer EV Robilotti, NE Babady, PA Mead, T Rolling, R Perez-Johnston, ... Nature medicine 26 (8), 1218-1223, 2020 | 634 | 2020 |
Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline MS Glickman, WR Jacobs Cell 104 (4), 477-485, 2001 | 552 | 2001 |
Mycobacterium tuberculosis nuoG Is a Virulence Gene That Inhibits Apoptosis of Infected Host Cells K Velmurugan, B Chen, JL Miller, S Azogue, S Gurses, T Hsu, M Glickman, ... PLoS pathogens 3 (7), e110, 2007 | 403 | 2007 |
Bacterial DNA repair by non-homologous end joining S Shuman, MS Glickman Nature Reviews Microbiology 5 (11), 852-861, 2007 | 325 | 2007 |
Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule V Rao, N Fujiwara, SA Porcelli, MS Glickman The Journal of experimental medicine 201 (4), 535-543, 2005 | 299 | 2005 |
A Gamma Interferon Independent Mechanism of CD4 T Cell Mediated Control of M. tuberculosis Infection in vivo AM Gallegos, JWJ van Heijst, M Samstein, X Su, EG Pamer, MS Glickman PLoS pathogens 7 (5), e1002052, 2011 | 263 | 2011 |
CarD is an essential regulator of rRNA transcription required for Mycobacterium tuberculosis persistence CL Stallings, NC Stephanou, L Chu, A Hochschild, BE Nickels, ... Cell 138 (1), 146-159, 2009 | 262 | 2009 |
Mechanism of nonhomologous end-joining in mycobacteria: a low-fidelity repair system driven by Ku, ligase D and ligase C C Gong, P Bongiorno, A Martins, NC Stephanou, H Zhu, S Shuman, ... Nature structural & molecular biology 12 (4), 304-312, 2005 | 254 | 2005 |
Delayed protection by ESAT-6–specific effector CD4+ T cells after airborne M. tuberculosis infection AM Gallegos, EG Pamer, MS Glickman The Journal of experimental medicine 205 (10), 2359-2368, 2008 | 238 | 2008 |
Trans -cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis –induced inflammation and virulence V Rao, F Gao, B Chen, WR Jacobs, MS Glickman The Journal of clinical investigation 116 (6), 1660-1667, 2006 | 235 | 2006 |
Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis C Huang, CV Smith, MS Glickman, WR Jacobs, JC Sacchettini Journal of Biological Chemistry 277 (13), 11559-11569, 2002 | 224 | 2002 |
Converting cancer therapies into cures: lessons from infectious diseases MS Glickman, CL Sawyers Cell 148 (6), 1089-1098, 2012 | 210 | 2012 |
Essential yet limited role for CCR2+ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming M Samstein, HA Schreiber, IM Leiner, B Sušac, MS Glickman, EG Pamer Elife 2, e01086, 2013 | 187 | 2013 |
Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed MF Wipperman, DW Fitzgerald, MAJ Juste, Y Taur, S Namasivayam, ... Scientific reports 7 (1), 10767, 2017 | 180 | 2017 |
The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase MS Glickman, SM Cahill, WR Jacobs Journal of Biological Chemistry 276 (3), 2228-2233, 2001 | 172 | 2001 |
Biochemical and genetic analysis of the four DNA ligases of mycobacteria C Gong, A Martins, P Bongiorno, M Glickman, S Shuman Journal of Biological Chemistry 279 (20), 20594-20606, 2004 | 169 | 2004 |
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy S Namasivayam, M Maiga, W Yuan, V Thovarai, DL Costa, LR Mittereder, ... Microbiome 5, 1-17, 2017 | 144 | 2017 |